Introduction: cardiometabolic considerations in COVID-19.
作者信息
Krentz Andrew J
机构信息
Institute for Cardiovascular and Metabolic Research, University of Reading, Reading, UK.
出版信息
Cardiovasc Endocrinol Metab. 2020 Jul 27;9(3):101. doi: 10.1097/XCE.0000000000000225. eCollection 2020 Sep.
Abstract
摘要
相似文献
1
Introduction: cardiometabolic considerations in COVID-19.引言：2019冠状病毒病中的心脏代谢相关考量
Cardiovasc Endocrinol Metab. 2020 Jul 27;9(3):101. doi: 10.1097/XCE.0000000000000225. eCollection 2020 Sep.
2
COVID-19 infection and cardiometabolic complications: short- and long-term treatment and management considerations.COVID-19 感染与心脏代谢并发症：短期和长期治疗及管理注意事项。
Rev Cardiovasc Med. 2021 Jun 30;22(2):263-265. doi: 10.31083/j.rcm2202031.
3
A network meta-analysis of association between cardiometabolic risk factors and COVID-19 outcome severity.一项关于心血管代谢风险因素与 COVID-19 结局严重程度关联的网络荟萃分析。
J Diabetes. 2023 Nov;15(11):968-977. doi: 10.1111/1753-0407.13445. Epub 2023 Aug 30.
4
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II).心血管代谢性多重合并症与比单个心血管代谢风险因素更差的 Covid-19 预后相关：一项多中心回顾性研究（CoViDiab II）。
Cardiovasc Diabetol. 2020 Oct 1;19(1):164. doi: 10.1186/s12933-020-01140-2.
5
Race Versus Social Determinants of Health in COVID-19 Hospitalization Prediction.种族与 COVID-19 住院预测中的健康社会决定因素。
Am J Prev Med. 2022 Jul;63(1 Suppl 1):S103-S108. doi: 10.1016/j.amepre.2022.01.034.
6
Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis.2019 年冠状病毒病住院归因于美国的心脏代谢疾病：比较风险评估分析。
J Am Heart Assoc. 2021 Feb;10(5):e019259. doi: 10.1161/JAHA.120.019259. Epub 2021 Feb 25.
7
Coronavirus Disease 2019 and Cardiometabolic Disease.新型冠状病毒肺炎与心血管代谢疾病。
Cardiol Rev. 2022;30(3):123-128. doi: 10.1097/CRD.0000000000000405.
8
Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19.心血管代谢性共病和种族对 COVID-19 患者心血管/肾脏并发症的影响。
Heart. 2022 Jul 13;108(15):1200-1208. doi: 10.1136/heartjnl-2021-320047.
9
Cardiometabolic Risk Factors for COVID-19 Susceptibility and Severity: A Mendelian Randomization Analysis.COVID-19易感性和严重程度的心血管代谢危险因素：一项孟德尔随机化分析
medRxiv. 2020 Sep 1:2020.08.26.20182709. doi: 10.1101/2020.08.26.20182709.
10
Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk: A 2-Sample Mendelian Randomization Study.与高心血管代谢风险人群中重症 COVID-19 相关的生物标志物：两样本 Mendelian 随机研究。
JAMA Netw Open. 2023 Jul 3;6(7):e2325914. doi: 10.1001/jamanetworkopen.2023.25914.
本文引用的文献
1
Cardiovascular and cardiometabolic prevention: high-level priority in the era of COVID-19.心血管与心脏代谢预防：新冠疫情时代的高度优先事项
Cardiovasc Endocrinol Metab. 2020 Jun 11;9(3):125-127. doi: 10.1097/XCE.0000000000000215. eCollection 2020 Sep.
Zotero 插件